<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-id journal-id-type="hwp">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27288456</article-id>
<article-id pub-id-type="pmc">5179922</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddw169</article-id>
<article-id pub-id-type="publisher-id">ddw169</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Loss of Magel2 impairs the development of hypothalamic Anorexigenic circuits</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Maillard</surname>
<given-names>Julien</given-names>
</name>
<xref ref-type="aff" rid="ddw169-aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ddw169-aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Soyoung</given-names>
</name>
<xref ref-type="aff" rid="ddw169-aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="ddw169-FN1">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Croizier</surname>
<given-names>Sophie</given-names>
</name>
<xref ref-type="aff" rid="ddw169-aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="ddw169-FN1">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vanacker</surname>
<given-names>Charlotte</given-names>
</name>
<xref ref-type="aff" rid="ddw169-aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cook</surname>
<given-names>Joshua H.</given-names>
</name>
<xref ref-type="aff" rid="ddw169-aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prevot</surname>
<given-names>Vincent</given-names>
</name>
<xref ref-type="aff" rid="ddw169-aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tauber</surname>
<given-names>Maithe</given-names>
</name>
<xref ref-type="author-notes" rid="ddw169-FN1">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bouret</surname>
<given-names>Sebastien G.</given-names>
</name>
<xref ref-type="aff" rid="ddw169-aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ddw169-aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="ddw169-cor1">*</xref>
</contrib>
<aff id="ddw169-aff1"><label>1</label>The Saban Research Institute, Developmental Neuroscience Program, Children’s Hospital Los Angeles, University of Southern California, Department of Pediatrics, Los Angeles, CA 90027, USA</aff>
<aff id="ddw169-aff2"><label>2</label>Inserm, Jean-Pierre Aubert Research Center, U1172, University Lille 2, Lille 59045, France</aff>
<aff id="ddw169-aff3"><label>3</label>Department of Endocrinology, Bone Diseases, Genetics, and Gynecology, Centre de Référence du Syndrome de Prader-Willi, Children's Hospital, Toulouse 31059, France</aff>
</contrib-group>
<author-notes>
<corresp id="ddw169-cor1">*To whom correspondence should be addressed at: Tel: +1-323-361-8743; Fax: +1-323-361-1549; Email: <email>sbouret@chla.usc.edu</email></corresp>
<fn id="ddw169-FN1">
<p><sup>†</sup>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>6</month>
<year>2016</year>
</pub-date>
<volume>25</volume>
<issue>15</issue>
<fpage>3208</fpage>
<lpage>3215</lpage>
<history>
<date date-type="received">
<day>26</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>5</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>Prader–Willi syndrome (PWS) is a genetic disorder characterized by a variety of physiological and behavioral dysregulations, including hyperphagia, a condition that can lead to life-threatening obesity. Feeding behavior is a highly complex process with multiple feedback loops that involve both peripheral and central systems. The arcuate nucleus of the hypothalamus (ARH) is critical for the regulation of homeostatic processes including feeding, and this nucleus develops during neonatal life under of the influence of both environmental and genetic factors. Although much attention has focused on the metabolic and behavioral outcomes of PWS, an understanding of its effects on the development of hypothalamic circuits remains elusive. Here, we show that mice lacking <italic>Magel2</italic>, one of the genes responsible for the etiology of PWS, display an abnormal development of ARH axonal projections. Notably, the density of anorexigenic α-melanocyte-stimulating hormone axons was reduced in adult <italic>Magel2</italic>-null mice, while the density of orexigenic agouti-related peptide fibers in the mutant mice appeared identical to that in control mice. On the basis of previous findings showing a pivotal role for metabolic hormones in hypothalamic development, we also measured leptin and ghrelin levels in <italic>Magel2</italic>-null and control neonates and found that mutant mice have normal leptin and ghrelin levels. <italic>In vitro</italic> experiments show that Magel2 directly promotes axon growth. Together, these findings suggest that a loss of <italic>Magel2</italic> leads to the disruption of hypothalamic feeding circuits, an effect that appears to be independent of the neurodevelopmental effects of leptin and ghrelin and likely involves a direct neurotrophic effect of Magel2.</p>
</abstract>
<counts>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>